Patents Assigned to VAXDYN, S.L.
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20220152184
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: September 29, 2021
    Publication date: May 19, 2022
    Applicants: VAXDYN S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • Vaccine against based on cellular components deficient in lipopolysaccharide
    Patent number: 11160856
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: November 2, 2021
    Assignees: Vaxdyn S.L., Fundación Pública Andaluza para la Gestión de la Investigación en Salud De Sevilla, Servicio Andaluz de Salud
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20180256700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: January 24, 2018
    Publication date: September 13, 2018
    Applicants: VAXDYN S.L, FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo
  • VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
    Publication number: 20170065700
    Abstract: The invention refers to a composition comprising inactivated cells deficient in LPS from the genus Acinetobacter and/or outer membrane vesicles form the same and their use for the manufacture of a medicament, preferably a vaccine, for the prevention of diseases produced by organisms of the genus Acinetobacter.
    Type: Application
    Filed: May 5, 2015
    Publication date: March 9, 2017
    Applicants: VAXDYN, S.L., FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA, SERVICIO ANDALUZ DE SALUD
    Inventors: Michael James McConnell, Meritxell García Quintanilla, Marina Pulido Toledano, María Pilar Pérez Romero, Jerónimo Pachón Díaz, Juan José Infante Viñolo